Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes
International Journal of Molecular Sciences · 03.01.2023 · 24 (1) · 854
DOI: 10.3390/ijms24010854 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.01.2023. Verfasst von Natalie Oberhuber und 6 weiteren Autor:innen. Beteiligte Einrichtung: Organic Chemistry 1, University of Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, Germany. Hauptthemen laut MEDLINE: Antineoplastic Agents, Protein Kinase Inhibitors, Tyrphostins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, United States Department of Defense, Department of Defense.
Abstract (Originalsprache)
New N-alkylindole-substituted 2-(pyrid-3-yl)-acrylonitriles with putative kinase inhibitory activity and their (p-cymene)Ru(II) piano-stool complexes were prepared and tested for their antiproliferative efficacy in various cancer models. Some of the indole-based derivatives inhibited tumor cell proliferation at (sub-)micromolar concentrations with IC50 values below those of the clinically relevant multikinase inhibitors gefitinib and sorafenib, which served as positive controls. A focus was set on the investigation of drug mechanisms in HCT-116 p53-knockout colon cancer cells in order to evaluate the dependence of the test compounds on p53. Colony formation assays as well as experiments with tumor spheroids confirmed the excellent antineoplastic efficacy of the new derivatives. Their mode of action included an induction of apoptotic caspase-3/7 activity and ROS formation, as well as anti-angiogenic properties. Docking calculations with EGFR and VEGFR-2 identified the two 3-aryl-2-(pyrid-3-yl)acrylonitrile derivatives 2a and 2b as potential kinase inhibitors with a preferential activity against the VEGFR-2 tyrosine kinase. Forthcoming studies will further unveil the underlying mode of action of the promising new derivatives as well as their suitability as an urgently needed novel approach in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organic Chemistry 1, University of Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, Germany.
- Department of Cancer Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA.
- Institute of Physiology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.
ORCID-Profile: Bianca Nitzsche, Rainer Schobert, Bernhard Biersack
Förderung
- Deutsche Forschungsgemeinschaft
- United States Department of Defense
- Department of Defense
- American Gastroenterological Association Research Scholar Award
- University of Kansas Cancer Center
Zitieren
APA
Oberhuber, N., Ghosh, H., Nitzsche, B., Dandawate, P., Höpfner, M., Schobert, R., & Biersack, B. (2023). Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes. International Journal of Molecular Sciences, 24(1), 854. https://doi.org/10.3390/ijms24010854
Vancouver
Oberhuber N, Ghosh H, Nitzsche B, Dandawate P, Höpfner M, Schobert R, et al. Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes. International Journal of Molecular Sciences. 2023;24(1):854. doi:10.3390/ijms24010854
BibTeX
@article{Oberhuber2023,
author = {Oberhuber, Natalie and Ghosh, Hindole and Nitzsche, Bianca and Dandawate, Prasad and Höpfner, Michael and Schobert, Rainer and Biersack, Bernhard},
title = {Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {1},
pages = {854},
doi = {10.3390/ijms24010854}
}
EUVIMED